低氧性脑血管扩张机制研究的概况

低氧可以通过多种机制影响脑血管的张力,改变脑血流量,进而影响脑功能。低氧性脑血管舒张机制是近年研究热点之一。本文从ＮＯ、前列环素、ＡＴＰ敏感Ｋ通道、ＡＴＰ、兴奋性氨基酸、Ｃａ＾＋＋等诸多方面论述了低氧性脑血管舒张可能的作用机制,并就有待解决的若干问题与读者进行讨论。     

急性低氧条件下高、低二氧化碳对脑血流的影响

在脑血流的调节中,动脉血液中的氧和二氧化碳是两个重要调节因素。当氧或二氧化碳的张力发生改变时,可引起脑血管阻力的改变,继而导致脑血流的变化。急性和慢性低氧往往伴随着机体二氧化碳的变化。在高原低氧环境中经常能见到人体的过度通气或通气不足现象,前者导致动脉血二氧化碳张力的降低,后者造成二氧化碳张力的升高。这种低氧和高、低二氧化碳结合作用于脑血管的现象不但可发生在高原     

一氧化氮参与低氧脑血管张力调节

本工作是初生小牛基底动脉血管条上,用一氧化氮合成酶抑制剂－Ｌ－硝基精氨酸研究ＮＯ及内皮细胞在低氧脑血管扩张机制中的作用。实验结果表明,Ｌ－ＮＮＡ可减弱低氧扩血管作用,但减少的值要小于常氧下相同浓度Ｌ－ＮＮＡ所引起的作用。     

一氧化氮对脑血流的调节

一氧化氮是近年来发现的一种重要的血管活性因子,它通过激活平滑肌细胞内水溶性鸟苷酸环化酶,而产生血管舒张作用,在正常生理条件下,ＮＯ不仅对外因管有作用,对脑血管也有作用,但关于它在低氧和高二氧化碳条件下脑血管是否具有调节作用还存在着争议。     

钾通道在肺动脉、脑基底动脉缺氧反应中的作用

钾通道在肺动脉、脑基底动脉缺氧反应中的作用刘杰,王迪浔（同济医科大学病理生理学教研室武汉４３００３０）肺、脑血管平滑肌及内皮细胞存在多种类型Ｋ＋通道,它们对血管张力的调节起着重要的作用。本实验拟探讨Ｋ＋通道在肺、脑血管缺氧反应中的作用。１材料与方法长...     

埃他卡林对低氧暴露大鼠脑和肺微动脉选择性扩张作用

目的:研究低氧暴露对大鼠脑和肺微动脉内皮功能的影响以及埃他卡林(Ipt)对以上微动脉的扩张作用特征。方法:将雄性SD大鼠随机分为2组,常压常氧组(control)和低氧暴露组(hypoxic),后者置于常压低氧暴露舱内(O27.8%)8 h。分离大鼠管径为(204±5)μm的脑基底动脉、肺微动脉组织,利用DMT微血管张力测定仪在6nmol/L内皮素-1(ET-1)致血管预收缩条件下,利用乙酰胆碱(ACh)考察微动脉内皮功能及观察不同浓度Ipt对脑和肺微动脉张力变化的影响。结果:与常压常氧组对比,10-5 mol/L乙酰胆碱(ACh)对低氧暴露脑肺微动脉扩张率显著降低(P0.05);新型ATP敏感性钾通道开放剂Ipt在(10-11~10-3)mol/L对低氧暴露肺微动脉呈剂量依赖性扩张作用,明显强于对常压常氧组(P0.01),在(10-11~10-3)mol/L对低氧暴露脑微动脉呈剂量依赖性扩张作用,但与常压常氧组相比无显著差异。结论:低氧暴露可导致脑基底动脉和肺微动脉内皮功能受损,Ipt具有选择性增强扩张低氧暴露肺微动脉的作用,但不影响以上条件低氧暴露后脑基底动脉的扩张作用,提示该药可应用于改善低氧暴露所致的肺微血管收缩,为Ipt发展为新型治疗肺动脉高压的药物提供理论基础。     

发现一种新神经递质:内皮-衍生松弛素

最近,科学家们发现,人体内有一种特殊的神经递质,它作用于脑血管内皮细胞和血管平滑肌细胞,具有一定的血管生理学意义。心血管学家称之为内皮—衍生松弛素(EDRF)。在血管系统中,EDRF是内皮细胞在血管舒张药,如乙酰胆碱、缓激肽和组织胺作用下释放的一种局部激素。EDRF扩散到血管平滑肌,通过活化鸟苷酸环化酶(GMP)引起血管扩张,同时使环鸟苷酸腺苷(cGMP)水平增加。多年来人们认为,中枢神经系统中兴奋性神经递质谷氨酸能触发cGMP的大量增加,特别是在cGMP转化率低的小脑中。     

埃他卡林对间歇性低氧暴露肺微动脉的选择性扩张作用

目的:研究新型ATP敏感性钾通道开放剂埃他卡林(Ipt)对间歇性低氧暴露肺微动脉扩张作用特征。方法:将雄性SD大鼠随机分为3组,对照组(Control),低氧暴露组,置于常压低氧舱内(O210%±0.5%)8 h/d,每周6d,和低氧暴露+醋氮酰胺(Acz)干预组(灌胃给予Acz 80 mg/(kg.d))。12周后分离大鼠管径为(197±4)μm的肺微动脉组织,利用DMT微血管张力测定仪在6 nmol/L内皮素-1(ET-1)致血管预收缩条件下,考察不同浓度Ipt对间歇性低氧暴露肺微动脉张力变化并利用ACh考察肺微动脉内皮活性。结果:与常压常氧组对比,10-5mol/LACh对间歇性低氧暴露肺微动脉舒张率显著降低(P<0.01),而与80 mg/kg Acz干预组肺微动脉舒张率无显著性差异(P>0.05);Ipt在(10-11~10-4)mol/L对间歇性低氧暴露肺微动脉呈剂量依赖性舒张作用,与80 mg/kg Acz干预组间无显著性差异(P>0.05),而对常压常氧组肺微动脉无明显的舒张作用。结论:间歇性低氧暴露肺微动脉内皮细胞功能受损,Ipt可选择性扩张低氧暴露肺微动脉;Acz可改善低氧所致内皮细胞功能异常,但并不影响Ipt对低氧暴露肺微动脉的选择性扩张作用。     

尼氟灭酸在大鼠低氧高二氧化碳性肺血管收缩中的作用

目的：探讨氯离子通道阻断剂一尼氟灭酸（NFA）在大鼠低氧高二氧化碳性肺血管收缩（HHPV）中的作用。方法：采用大鼠HHPV模型,二、三级动脉环分别随机分4组（n=8）：常氧组（N组）、低氧高二氧化碳组（H组）、DMSO组（HD组）、尼氟灭酸组（NFA组）。在急性低氧高二氧化碳介质中,采用NFA分别孵育肺二、三级肺动脉环,按照低氧高二氧化碳反应性测定的方法测定其二、三级肺动脉血管环张力的变化,并观察NFA对HHPV的影响。结果：①H组二、三级肺动脉均呈现双向性收缩变化（I期快速收缩、快速舒张;II期持续性收缩）与N组相比有显著性差异（P〈0．05,P〈0．01）;②NFA组二、三级肺动脉环的低氧高二氧化碳性血管收缩作用明显减弱,尤其是Ⅱ期的持续收缩,与HD组相比有显著性差异（P〈0．05,P〈0．01）。结论：氯离子通道阻断剂一尼氟灭酸可减轻大鼠二、三级肺动脉环的张力变化率（尤其是Ⅱ期的持续性收缩）,从而发挥拮抗HHPV的作用。     

缺氧、吸烟和血管活性物质对肺动脉内皮细胞产生前列环素和血栓素A_2的影响

内皮细胞不仅是血液与组织间液之间的屏障,而且具有广泛的代谢功能,从而调节肺血管张力及对缺氧的反应性。前列环素(PGI_2)和血栓素A_2(TXA_2)在内皮细胞内的代谢非常活跃,在缺氧性肺血管收缩反应(HPV)中起重要作用。吸烟是慢性肺心病和肺动脉高压的主要病因之一。有研究表     

Ozone inhibits prostacyclin synthesis in pulmonary endothelium

The effects of ozone on lung arachidonate metabolism in-vitro were studied in cultured bovine pulmonary endothelial cells exposed for 2 hours to ozone in concentrations up to 1.0 ppm. A concentration-dependent decrease in prostacyclin synthesis was found (90% decrease at the highest ozone level of 1.0 ppm). The inhibition of prostacyclin synthesis was not due to a decreased release of arachidonic acid from membrane lipids. We also examined the hypoxic pulmonary vasoconstrictive response to 10% oxygen inhalation in anesthetized dogs in-vivo after exposure to 1.0 ppm ozone for 1 hour. Pulmonary vascular resistance was significantly increased after ozone exposure, similar to the findings in dogs given indomethacin (15 mg/kg). The percentage change in the hypoxic pulmonary pressor response was similar between the ozone exposure and indomethacin-treated groups, although due to the variance of the pulmonary vascular resistance values during hypoxia the results did not reach statistical significance. These results suggest that ozone inhalation affects pulmonary endothelial arachidonate metabolism in-vivo as well as in-vitro.     

Ca2+ sensitization during sustained hypoxic pulmonary vasoconstriction is endothelium dependent

The main aim of this study was to determine the effects of endothelium removal on tension and intracellular Ca(2+) ([Ca(2+)](i)) during hypoxic pulmonary vasoconstriction (HPV) in rat isolated intrapulmonary arteries (IPA). Rat IPA and mesenteric arteries (MA) were mounted on myographs and loaded with the Ca(2+)-sensitive fluorophore fura PE-3. Arteries were precontracted with prostaglandin F(2alpha), and the effects of hypoxia were examined. HPV in isolated IPA consisted of a transient constriction superimposed on a second sustained phase. Only the latter phase was abolished by endothelial denudation. However, removal of the endothelium had no effect on [Ca(2+)](i) at any point during HPV. The endothelin-1 antagonists BQ-123 and BQ-788 did not affect HPV, although constriction induced by 100 nM endothelin-1 was abolished. In MA, hypoxia induced an initial transient rise in tension and [Ca(2+)](i), followed by vasodilatation and a fall in [Ca(2+)](i) to (but not below) prehypoxic levels. These results are consistent with sustained HPV being mediated by an endothelium-derived constrictor factor that is distinct from endothelin-1 and that elicits vasoconstriction via Ca(2+) sensitization.     

Neuropeptide Y enhances permeability across a rat aortic endothelial cell monolayer

Previously, in vivo studies showed that neuropeptide Y (NPY) elevates vascular permeability in isolated lung perfusion preparations, possibly through binding to the NPY Y(3) receptor. The present study used monolayers in a double-chamber culture method under conditions of normoxia (5% CO(2)-20% O(2)-75% N(2)) or hypoxia (5% CO(2)-5% O(2)-90% N(2)) to test the hypothesis that NPY directly affects rat aortic endothelial cells (RAECs). RAECs were cultured on the base of the upper chamber, into which FITC-labeled albumin was introduced, and permeation into the lower chamber was measured. The RAEC monolayer was treated with 10(-8)-3 x 10(-7) M NPY for 2 h in normoxia or hypoxia. In hypoxia, NPY concentration dependently increased the permeability of the RAEC monolayer, whereas in normoxia no significant change was observed. Peptide YY, NPY Y(1), and NPY Y(2) receptor agonists and NPY Y(1) receptor antagonist exerted no significant effects under hypoxic conditions. NPY-(18-36), an NPY Y(3) receptor antagonist, elicited an inhibitory action on the NPY-induced increase in monolayer permeability. Furthermore, neither N-monomethyl-l-arginine, a nitric oxide synthase inhibitor, the bradykinin B(2) receptor antagonist FK-3657, nor the vascular endothelial growth factor receptor-coupled tyrosine kinase inhibitor tyrphostin SU-1498, injected into the medium of the upper chamber, affected the NPY-induced permeability changes under hypoxic conditions. The results suggest that the NPY-induced increase in permeability across the RAEC monolayer is closely related to low O(2) tension, possibly mediated by direct action on the NPY Y(3) receptor expressed on the endothelial cell membrane. Furthermore, this NPY-induced increase is not likely due to nitric oxide, bradykinin, or vascular endothelial growth factor.     

Resistin impairs endothelium-dependent dilation to bradykinin, but not acetylcholine, in the coronary circulation

Elevated plasma levels of fat-derived signaling molecules are associated with obesity, vascular endothelial dysfunction, and coronary heart disease; however, little is known about their direct coronary vascular effects. Accordingly, we examined mechanisms by which one adipokine, resistin, affects coronary vascular tone and endothelial function. Studies were conducted in anesthetized dogs and isolated coronary artery rings. Resistin did not change coronary blood flow, mean arterial pressure, or heart rate. Resistin had no effect on acetylcholine-induced relaxation of artery rings; however, resistin did impair bradykinin-induced relaxation. Selective impairment was also observed in vivo, as resistin attenuated vasodilation to bradykinin but not to acetylcholine. Resistin had no effect on dihydroethidium fluorescence, an indicator of superoxide (O(2)(-)) production, and the inhibitory effect of resistin on bradykinin-induced relaxation persisted in the presence of Tempol, a superoxide dismutase mimetic. To determine whether resistin impaired production of and/or responses to nitric oxide (NO) or prostaglandins (e.g., prostacyclin; PGI(2)), we performed experiments with N(omega)-nitro-L-arginine methyl ester (L-NAME) and indomethacin. The effect of resistin to attenuate bradykinin-induced vasodilation persisted in the presence of L-NAME or indomethacin, suggesting resistin may act at a cell signaling point upstream of NO or PGI(2) production. Resistin-induced endothelial dysfunction is not generalized, and it is not consistent with effects mediated by O(2)(-) or interference with NO or PGI(2) signaling. The site of the resistin-induced impairment is unknown but may be at the bradykinin receptor or a closely associated signal transduction machinery proximal to NO synthase or cyclooxygenase.     

Age-dependent modulation of endothelium-dependent vasodilatation by chronic hypoxia in ovine cranial arteries.

Although abundant evidence indicates that chronic hypoxia can induce pulmonary vascular remodeling, very little is known of the effects of chronic hypoxia on cerebrovascular structure and function, particularly in the fetus. Thus the present study explored the hypothesis that chronic hypoxemia also influences the size and shape of cerebrovascular smooth muscle and endothelial cells, with parallel changes in the reactivity of these cells to endothelium-dependent vasodilator stimuli. To test this hypothesis, measurements of endothelial and vascular smooth muscle cell size and density were made in silver-stained common carotid and middle cerebral arteries from term fetal and nonpregnant adult sheep maintained at an altitude of 3,820 m for 110 days. Chronic hypoxia induced an age-dependent remodeling that led to smooth muscle cells that were larger in fetal arteries but smaller in adult arteries. Chronic hypoxia also increased endothelial cell density in fetal arteries but reduced it in adult arteries. These combined effects resulted in an increased (adult carotid), decreased (adult middle cerebral), or unchanged (fetal arteries) per cell serosal volume of distribution for endothelial factors. Despite this heterogeneity, the magnitude of endothelium-dependent vasodilatation to A23187, measured in vitro, was largely preserved, although sensitivity to this relaxant was uniformly depressed. N(G)-nitro-L-arginine methyl ester, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, and endothelium denudation each independently blocked A23187-induced vasodilation without unmasking any residual vasoconstrictor effect. Indomethacin did not significantly attenuate A23187-induced relaxation except in the hypoxic adult middle cerebral, where a small contribution of prostanoids was evident. Vascular sensitivity to exogenous nitric oxide (NO) was uniformly increased by chronic hypoxia. From these results, we conclude that chronic hypoxia reduced endothelial NO release while also upregulating some component of the NO-cGMP-PKG vasodilator pathway. These offsetting effects appear to preserve endothelium-dependent vasodilation after adaptation to chronic hypoxia.     

缺氧对新生小牛肺血管平滑肌细胞增殖的影响及764—3的抑制作用

本研究应用细胞培养、~3H—TdR参入技术,探讨缺氧对新生小牛肺血管平滑肌细胞(PASMC)DNA合成和细胞增殖的影响及746—3和川芎嗪抗细胞增殖效果。结果表明:缺氧的肺血管内皮细胞(PAEC)培养液可以明显增加PASMC中~3H—TdR的参入;缺氧24h亦可直接刺激PASMC,使其中~3H—TdR的参入显著增加(P<0.001);在缺氧的PASMC培养基中加入764—3,~3H—TdR参入值与单纯缺氧组相比显著下降,并使细胞数减少36.3％,764—3还可以显著抑制常氧PASMC的增殖;川芎嗪的作用较小。实验结果提示,缺氧不仅可以刺激内皮细胞(EC)产生促分裂素使PASMC增殖,而且还可以直接刺激PASMC的增殖,764—3可抑制缺氧及血清刺激的PASMC的增殖。     

Effect of hypoxia on prostacyclin production in cultured pulmonary artery endothelium

Exposure of cultured bovine pulmonary artery endothelial cells to varying levels of hypoxia (10% or 0% O2) for 4 hours resulted in a significant dose-dependent inhibition in endothelial prostacyclin synthesis (51% and 98%, at the 10% and 0% O2 levels respectively, p less than 0.05, compared to 21% O2 exposure values). Release of 3H-arachidonic acid from cellular pools was not altered by hypoxia. Some of the cells were incubated with arachidonic acid (20 microM for 5 min) or PGH2 (4 microM for 2 min) immediately after exposure. Endothelium exposed to 0% O2, but not to 10% O2, produced significantly less prostacyclin after addition of either arachidonic acid (25 +/- 5% of 21% O2 exposure values, n = 6, p less than 0.01) or PGH2 (31 +/- 3% of 21% O2 exposure values, n = 6, p less than 0.05). These results suggest that hypoxia inhibits cyclooxygenase at the 10% O2 level and both cyclooxygenase and prostacyclin synthetase enzymes at the 0% O2 exposure levels. Exposure of aortic endothelial cells resulted in a 44% inhibition of prostacyclin at the 0% exposure level. No significant alteration in prostacyclin production was found in pulmonary vascular smooth muscle cells exposed to hypoxia. These data suggest that the increased prostacyclin production reported in lungs exposed to hypoxia is not due to a direct effect of hypoxia on the main prostacyclin producing cells of the pulmonary circulation.     

Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway

Cyclic AMP (cAMP) is a well-known intracellular signaling molecule improving barrier function in vascular endothelial cells. Here, we delineate a novel cAMP-triggered signal that regulates the barrier function. We found that cAMP-elevating reagents, prostacyclin and forskolin, decreased cell permeability and enhanced vascular endothelial (VE) cadherin-dependent cell adhesion. Although the decreased permeability and the increased VE-cadherin-mediated adhesion by prostacyclin and forskolin were insensitive to a specific inhibitor for cAMP-dependent protein kinase, these effects were mimicked by 8-(4-chlorophenylthio)-2'-O-methyladenosine-3', 5'-cyclic monophosphate, a specific activator for Epac, which is a novel cAMP-dependent guanine nucleotide exchange factor for Rap1. Thus, we investigated the effect of Rap1 on permeability and the VE-cadherin-mediated cell adhesion by expressing either constitutive active Rap1 or Rap1GAPII. Activation of Rap1 resulted in a decrease in permeability and enhancement of VE-cadherin-dependent cell adhesion, whereas inactivation of Rap1 had the counter effect. Furthermore, prostacyclin and forskolin induced cortical actin rearrangement in a Rap1-dependent manner. In conclusion, cAMP-Epac-Rap1 signaling promotes decreased cell permeability by enhancing VE-cadherin-mediated adhesion lined by the rearranged cortical actin.